Suppr超能文献

喷雾干燥药物-氨基酸共无定形制剂的工艺优化与放大

Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations.

作者信息

Kasten Georgia, Duarte Íris, Paisana Maria, Löbmann Korbinian, Rades Thomas, Grohganz Holger

机构信息

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Department of R&D Drug Product Development, Hovione FarmaCiencia SA, Estrada do Paço do Lumiar, Building S, 1649-038 Lisbon, Portugal.

出版信息

Pharmaceutics. 2019 Jan 9;11(1):24. doi: 10.3390/pharmaceutics11010024.

Abstract

The feasibility of upscaling the formulation of co-amorphous indomethacin-lysine from lab-scale to pilot-scale spray drying was investigated. A 2² full factorial design of experiments (DoE) was employed at lab scale. The atomization gas flow rate (F, from 0.5 to 1.4 kg/h) and outlet temperature (T, from 55 to 75 °C) were chosen as the critical process parameters. The obtained amorphization, glass transition temperature, bulk density, yield, and particle size distribution were chosen as the critical quality attributes. In general, the model showed low F and high T to be beneficial for the desired product characteristics (a co-amorphous formulation with a low bulk density, high yield, and small particle size). In addition, only a low F and high T led to the desired complete co-amorphization, while a minor residual crystallinity was observed with the other combinations of F and T. Finally, upscaling to a pilot scale spray dryer was carried out based on the DoE results; however, the drying gas flow rate and the feed flow rate were adjusted to account for the different drying chamber geometries. An increased likelihood to achieve complete amorphization, because of the extended drying chamber, and hence an increased residence time of the droplets in the drying gas, was found in the pilot scale, confirming the feasibility of upscaling spray drying as a production technique for co-amorphous systems.

摘要

研究了将实验室规模的共无定形吲哚美辛-赖氨酸制剂放大至中试规模喷雾干燥的可行性。在实验室规模采用了2²全因子实验设计(DoE)。选择雾化气体流速(F,0.5至1.4 kg/h)和出口温度(T,55至75°C)作为关键工艺参数。选择获得的非晶化、玻璃化转变温度、堆积密度、产率和粒度分布作为关键质量属性。总体而言,模型显示低F和高T有利于获得所需的产品特性(一种具有低堆积密度、高产率和小粒径的共无定形制剂)。此外,只有低F和高T才能实现所需的完全共无定形,而在F和T的其他组合中观察到有少量残余结晶度。最后,根据DoE结果进行了放大至中试规模喷雾干燥器的操作;然而,对干燥气体流速和进料流速进行了调整,以考虑不同的干燥室几何形状。在中试规模中发现,由于干燥室的延长,实现完全非晶化的可能性增加,因此液滴在干燥气体中的停留时间增加,这证实了将喷雾干燥放大作为共无定形系统生产技术的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca8/6358949/b591289266d5/pharmaceutics-11-00024-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验